J&J Builds Up Asia OTC, Rx Manufacturing Hub In Xi’an
This article was originally published in The Tan Sheet
Executive Summary
J&J is investing $290 million in its Xian Janssen Pharma division to build up an Asian manufacturing hub for pharma and OTC products. The site increases the firm’s manufacturing area more than seven times from 36,000 to 267,000 square meters.